Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O4EU
|
||||
Former ID |
DAP001343
|
||||
Drug Name |
Acrivastine
|
||||
Synonyms |
Acrivastin; Acrivastina; Acrivastinum; Semprex; Acrivastina [Spanish]; Acrivastinum [Latin]; Benadryl allergy relief; BW 0270C; BW 825C; BW A825C; BW-825C; Acrivastine (USAN/INN); Acrivastine [USAN:INN:BAN]; E-(9CI); (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; (E,E)-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid; 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Approved | [534869] | ||
Therapeutic Class |
Antiinflammatory Agents
|
||||
Company |
Pfizer Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H24N2O2
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O
|
||||
InChI |
1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+
|
||||
InChIKey |
PWACSDKDOHSSQD-IUTFFREVSA-N
|
||||
CAS Number |
CAS 87848-99-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7978641, 11039320, 11528790, 12012900, 14827611, 17396918, 39317835, 48415515, 50478506, 57359099, 92719198, 92729786, 93166367, 93309492, 99299401, 103374556, 104178336, 109614385, 113863077, 117544906, 124893773, 126628312, 126651909, 126670557, 127327803, 134338557, 135260703, 137100857, 142971128, 144206566, 162180352, 175268536, 179151367, 185967402, 196106033, 223447811, 223683999, 223704756, 226396645, 252344698
|
||||
SuperDrug ATC ID |
R06AX18
|
||||
SuperDrug CAS ID |
cas=087848995
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [534875], [537691] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.